Cita APA (7a ed.)
Ashfaq, W., Rehman, K., Shahid, A., & Younis, M. N. (Sep 2024). Therapeutic response and safety of radioligand therapy with 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer patients. Medical Oncology. https://doi.org/10.1007/s12032-024-02466-7
Cita Chicago Style (17a ed.)
Ashfaq, Wardah, Khurram Rehman, Abubaker Shahid, y Muhammad Numair Younis. "Therapeutic Response and Safety of Radioligand Therapy with 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer Patients." Medical Oncology Sep 2024. https://doi.org/10.1007/s12032-024-02466-7.
Cita MLA (9a ed.)
Ashfaq, Wardah, et al. "Therapeutic Response and Safety of Radioligand Therapy with 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer Patients." Medical Oncology, Sep 2024, https://doi.org/10.1007/s12032-024-02466-7.
Precaución: Estas citas no son 100% exactas.